SHIPPEO
7.12.2022 11:55:36 CET | Business Wire | Press release
Shippeo, a leading provider of global and multimodal shipment visibility, announced major platform enhancements as part of their feature-packed 2022 Autumn platform release at their Visibility Now! event in Paris. The update brings a range of new, disruptive capabilities to their Ocean Visibility solution, higher accuracy carbon emissions calculations powered by specialist Searoutes, and a range of general enhancements aimed at boosting data quality, usability and supply chain ecosystem collaboration.
“We know that supply chain resiliency is top of mind for supply chain executives and that dynamic operational visibility is foundational for resilience,” explains Anand Medepalli, Chief Product Officer at Shippeo. “Our latest platform release brings a range of exciting features and capabilities, arming organizations with the tools and knowledge to make quicker decisions, mitigate disruptions and collaborate with trading partners in real time, so that supply chain actors can design, plan and run the most profitable, sustainable and resilient supply chains.”
“The enormous challenges and uncertainty around ocean shipping, and growing internal and external pressures for businesses to operate more sustainably, are key drivers for the exciting innovations we’re introducing in our Autumn release, delivering significant value for our customers. We know that Shippeo’s value comes from us being a reliable visibility platform with a strong carrier network delivering high quality visibility data and meaningful insights with an intuitive user experience. These are precisely the areas our product team focused on in 2022.”
Major enhancements to Ocean Visibility platform including a new Port Insights engine
Shippeo’s latest Ocean Visibility solution updates provide customers with more useful, higher-quality ocean transport data, thanks to a new tech architecture supporting data quality and scalability improvements, making it possible to track an unlimited number of containers across multiple data sources. In addition, new dashboards provide powerful insights to aid in contract negotiations with carriers.
Enhanced demurrage and detention analytics down to a port pair level make it easier to identify and proactively react to affected containers. New Lane Insights highlight lead time, punctuality, transshipment duration, and more, offering new network analysis tools for shippers. Shippers can identify weak spots, such as ports or carriers experiencing frequent delays, and access lane analysis for specific routes.
Port Insights provides shippers with a better understanding of congestion and efficiency at ports throughout the world. In addition, by drawing on Shippeo’s multi-year research into ETA algorithms and geofencing technology, users benefit from best-in-class vessel ETAs, promising significant accuracy improvements over those provided by shipping lines. Through combining historical data with live AIS satellite data, terrestrial data and vessel schedule data, Shippeo’s Port Insights engine generates more accurate arrival and departure events at marine ports, resulting in the highest fidelity visibility of journeys and milestones for any shipment.
“We believe our Ocean Visibility platform offers the most accurate view available of what’s happening for any port on the planet,” says Medepalli. “With insights on more than 3000 ports worldwide, we offer customers a more complete and accurate understanding of their vessel routes. Along with our enhanced Demurrage and Detention dashboard, Lane Insights and best-in-class vessel ETA algorithm, our latest ocean product update is a disruptive, market-leading solution. And, as it is built on the same platform as our Road, Air and Rail Visibility solutions, we can help track multimodal shipments, regardless of which modes are used.”
New Searoutes partnership for reliable, global CO2 emission calculations
Shippeo’s Carbon Visibility product takes granular shipment level data, including routes, mileage, and more, to estimate carbon emissions attributable to road, ocean, inland waterway, rail and air shipments. A new platform integration with specialist carbon emissions estimating company Searoutes now allows accredited, higher quality carbon, and other greenhouse gas-equivalent emissions calculations across all transport modes in a single platform.
Searoutes also offers the unique benefit of modeled calculations for both milk-runs over road, and for ocean shipments. Advanced algorithms and a more detailed analysis, mean emissions are now less likely to be overstated and insights are more actionable.
“By combining Shippeo’s high quality data and Searoutes’s state-of-the-art models, our platform offers a unique and powerful Carbon Visibility solution to help our customers run sustainable supply chains,” explains Medepalli. “Our approach to carbon reporting simplifies effort for shippers and carriers by combining analysis across all modes in a single platform, and makes it possible to review carbon footprint at different levels of granularity, such as by region or business unit.”
Searoutes CEO, Pierre Garreau, expresses his delight about the partnership. “Searoutes was founded to find ways to use the latest data modeling and AI to solve the dual challenge of lowering fuel consumption and carbon emissions in one of the biggest contributing sectors to climate change; transportation,” says Garreau. “Today, Shippeo offers the best visibility data stewardship out there, so the mix of their excellent data quality with top-notch greenhouse gas emissions modeling from Searoutes will give customers the ability to have extremely accurate emissions reporting to help figure out a baseline for determining the best supply chain strategy, as they navigate an increasingly regulated shipping landscape.”
Platform innovations boosting data quality, usability and supply chain ecosystem collaboration
Along with Ocean and Carbon Visibility solution enhancements, Shippeo has introduced a number of other platform updates to propel its category-leading data intelligence capabilities even further. It’s now easier to detect broken telematics units with Shippeo platform’s unique Smart Tracking Analyzer, a tool which analyzes root-causes of low tracking rates and prescribes actions for users to remedy them. In addition, it’s now possible for users to update transport orders and add milestone events, such as multiple delivery attempts, even after transportation has finished, so that recorded information can be made more accurate, contributing to overall quality of visibility data.
In parallel, a new Notifications Builder offers platform users the ability to fully configure, customize and white label notifications. With a simple UI, the tool introduces greater flexibility for new ways to communicate and collaborate with ecosystem partners.
Watch Shippeo’s full autumn platform release announcement
About Searoutes
Searoutes specializes in innovative digital solutions for sustainability within the sea, air and logistics sector. The company is rooted in its proprietary routing algorithms that use historical ship data collected from AIS signals that allow for greater accuracy through superior methodologies. Today, Searoutes has developed a comprehensive collection of APIs to search, report and plan on real-time routes and CO2 emissions for all modes of transport to facilitate the decarbonization of freight transport.
About Shippeo
Shippeo is a global leader in real-time multimodal transportation visibility, helping major shippers and logistics service providers operate more collaborative, automated, sustainable, profitable, and customer-centric supply chains. This is made possible with highly accurate, real-time operational visibility and perfect workflow orchestration. Their Multimodal Visibility Network integrates with more than 875 TMS, telematics and ELD systems, enabling Shippeo’s platform to provide instant access to real-time shipment tracking across all transport modes, in a single portal, through an intuitive user experience. A proprietary and industry-leading machine learning algorithm offers unmatched ETA accuracy, allowing supply chain companies to quickly anticipate problems, proactively alert customers, efficiently manage exceptions with collaborative workflows, and accurately measure CO2 and GHG emissions from supply chain transport. Hundreds of customers, including global brands like Coca-Cola HBC, Carrefour, Renault Group, Schneider Electric, Total, Siemens Energy, Faurecia, Saint-Gobain and Eckes Granini, trust Shippeo to track more than 28 million shipments per year across 95 countries. Learn more at www.shippeo.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005768/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
